Target Evaluation & Molecular Therapeutics Group
Dr Olivia Rossanese’s group is investigating new targets to support the discovery of novel therapeutics to treat cancer. The group is also defining the molecular and genetic factors governing a cancer’s sensitivity to treatment with new drugs, to guide their clinical use.